Zacks Rates FUJIFILM Stock as ‘Strong Buy’

Zacks Investment Research has upgraded its ranking of FUJIFILM Holdings Corporation to a “Strong Buy,” its highest rating.

Advertisement

The company’s medical systems business is expected to demonstrate double digit year over year growth in 2015, according to the report.

More Articles on Devices:
FUJIFILM Breast Imaging Solution Earns FDA 510(k) Clearance
26 GI/Endoscopy Devices Receive FDA 510(k) Clearance in 2014
FUJIFILM Medical Systems Launches New Technology at ATS International Conference

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.